G. Vacca

645 total citations
16 papers, 482 citations indexed

About

G. Vacca is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, G. Vacca has authored 16 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 6 papers in Neurology and 5 papers in Oncology. Recurrent topics in G. Vacca's work include Multiple Sclerosis Research Studies (10 papers), Polyomavirus and related diseases (5 papers) and Systemic Lupus Erythematosus Research (4 papers). G. Vacca is often cited by papers focused on Multiple Sclerosis Research Studies (10 papers), Polyomavirus and related diseases (5 papers) and Systemic Lupus Erythematosus Research (4 papers). G. Vacca collaborates with scholars based in Italy and United States. G. Vacca's co-authors include Vincenzo Brescia Morra, Giuseppe Orefice, Roberta Lanzillo, Mario Quarantelli, Anna Prinster, Arturo Brunetti, Elena Salvatore, Bruno Alfano, Marco Salvatore and Giangennaro Coppola and has published in prestigious journals such as NeuroImage, Neurology and Journal of the Neurological Sciences.

In The Last Decade

G. Vacca

15 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Vacca Italy 14 302 132 128 79 77 16 482
A. Beheshtian United States 4 496 1.6× 237 1.8× 150 1.2× 67 0.8× 59 0.8× 6 584
Valentina Poretto Italy 7 406 1.3× 181 1.4× 118 0.9× 64 0.8× 100 1.3× 12 495
J Furby United Kingdom 8 331 1.1× 119 0.9× 105 0.8× 34 0.4× 55 0.7× 8 400
D. S. Dougherty United States 4 494 1.6× 199 1.5× 194 1.5× 48 0.6× 62 0.8× 4 553
Mari Heininen‐Brown United States 8 425 1.4× 124 0.9× 78 0.6× 41 0.5× 156 2.0× 13 577
A. Grop Italy 6 508 1.7× 196 1.5× 144 1.1× 96 1.2× 79 1.0× 7 561
Jacqueline Durfee United States 12 510 1.7× 178 1.3× 164 1.3× 71 0.9× 177 2.3× 14 743
E. Frohman United States 7 527 1.7× 195 1.5× 207 1.6× 31 0.4× 71 0.9× 8 829
Uroš Rot Slovenia 12 221 0.7× 137 1.0× 101 0.8× 45 0.6× 55 0.7× 31 524
Nuhad Abou Zeid United States 6 370 1.2× 173 1.3× 103 0.8× 75 0.9× 21 0.3× 8 450

Countries citing papers authored by G. Vacca

Since Specialization
Citations

This map shows the geographic impact of G. Vacca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Vacca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Vacca more than expected).

Fields of papers citing papers by G. Vacca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Vacca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Vacca. The network helps show where G. Vacca may publish in the future.

Co-authorship network of co-authors of G. Vacca

This figure shows the co-authorship network connecting the top 25 collaborators of G. Vacca. A scholar is included among the top collaborators of G. Vacca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Vacca. G. Vacca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Cervo, Amedeo, Sirio Cocozza, Francesco Saccà, et al.. (2014). The combined use of conventional MRI and MR spectroscopic imaging increases the diagnostic accuracy in amyotrophic lateral sclerosis. European Journal of Radiology. 84(1). 151–157. 17 indexed citations
2.
Liuzzi, Raffaele, Vincenzo Brescia Morra, Roberta Lanzillo, et al.. (2014). JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level. Therapeutics and Clinical Risk Management. 10. 807–807. 13 indexed citations
3.
Moccia, Marcello, Roberta Lanzillo, Raffaele Palladino, et al.. (2014). Uric acid: a potential biomarker of multiple sclerosis and of its disability. Clinical Chemistry and Laboratory Medicine (CCLM). 53(5). 753–9. 35 indexed citations
4.
Lanzillo, Roberta, Marcello Mancini, Raffaele Liuzzi, et al.. (2013). Chronic cerebrospinal venous insufficiency in multiple sclerosis: a highly prevalent age-dependent phenomenon. BMC Neurology. 13(1). 20–20. 18 indexed citations
5.
Lanzillo, Roberta, Simona Bonavita, Mario Quarantelli, et al.. (2012). Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice. Neurological Sciences. 34(4). 521–528. 15 indexed citations
6.
Lanzillo, Roberta, Raffaele Liuzzi, G. Vacca, et al.. (2012). Assessment and Concordance of Serum Anti JC Virus Antibodies and JCV DNA Presence in Multiple Sclerosis Natalizumab Treated Patients (P07.054). Neurology. 78(Meeting Abstracts 1). P07.054–P07.054.
7.
Lanzillo, Roberta, Carolina Di Somma, Mario Quarantelli, et al.. (2011). Insulin-like growth factor (IGF)-I and IGF-binding protein-3 serum levels in relapsing-remitting and secondary progressive multiple sclerosis patients. European Journal of Neurology. 18(12). 1402–1406. 18 indexed citations
8.
Lanzillo, Roberta, Mario Quarantelli, Simona Bonavita, et al.. (2011). Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: a head-to-head retrospective study. Acta Neurologica Scandinavica. 126(5). 306–314. 21 indexed citations
9.
Lanzillo, Roberta, Giuseppe Orefice, Mario Quarantelli, et al.. (2010). Atorvastatin Combined To Interferon to Verify the Efficacy (ACTIVE) in relapsing— remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy. Multiple Sclerosis Journal. 16(4). 450–454. 65 indexed citations
10.
Prinster, Anna, Mario Quarantelli, Roberta Lanzillo, et al.. (2009). A voxel-based morphometry study of disease severity correlates in relapsing— remitting multiple sclerosis. Multiple Sclerosis Journal. 16(1). 45–54. 39 indexed citations
11.
Coppola, Giangennaro, Roberta Lanzillo, C. Florio, et al.. (2006). Long‐term clinical experience with weekly interferon beta‐1a in relapsing multiple sclerosis. European Journal of Neurology. 13(9). 1014–1021. 23 indexed citations
12.
Striano, Pasquale, Antonietta Coppola, G. Vacca, et al.. (2006). Levetiracetam for cerebellar tremor in multiple sclerosis. Journal of Neurology. 253(6). 762–766. 31 indexed citations
13.
Annunziata, Pasquale, Antonio Giorgio, Lorenzo De Santi, et al.. (2006). Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-β. Journal of the Neurological Sciences. 244(1-2). 97–102. 31 indexed citations
14.
Prinster, Anna, Mario Quarantelli, Giuseppe Orefice, et al.. (2005). Grey matter loss in relapsing–remitting multiple sclerosis: A voxel-based morphometry study. NeuroImage. 29(3). 859–867. 141 indexed citations
15.
Marano, Enrico, et al.. (2003). HELLP syndrome with reversible posterior leukoencephalopathy. Neurological Sciences. 24(2). 82–84. 13 indexed citations
16.
Orefice, Giuseppe, Vincenzo Brancaccio, Giovanni Coppola, et al.. (2002). Comparative effects of mesoglycan and ticlopidine treatment on some coagulative parameters in patients with previous ischemic stroke: results of a randomized controlled trial. Current Therapeutic Research. 63(5). 337–343. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Beheshtian Breakdown of academic impact, for papers by Valentina Poretto Breakdown of academic impact, for papers by J Furby Breakdown of academic impact, for papers by D. S. Dougherty Breakdown of academic impact, for papers by Mari Heininen‐Brown Breakdown of academic impact, for papers by A. Grop Breakdown of academic impact, for papers by Jacqueline Durfee Breakdown of academic impact, for papers by E. Frohman Breakdown of academic impact, for papers by Uroš Rot Breakdown of academic impact, for papers by Nuhad Abou Zeid
Rankless by CCL
2026